Eupraxia Pharmaceuticals (EPRX) Exchange Rate Effect (2023 - 2026)

Eupraxia Pharmaceuticals (EPRX) has 4 years of Exchange Rate Effect data on file, last reported at -$448176.0 in Q1 2026.

• On a quarterly basis, Exchange Rate Effect changed N/A year-over-year to -$448176.0 in Q1 2026; TTM through Mar 2026 was -$903289.0, a N/A change from a year earlier, with the FY2025 full-year figure at $544813.0, up 127.87% from the prior year.
• Exchange Rate Effect for Q1 2026 stood at -$448176.0, down from $33894.0 in the prior quarter.
• Over the last five years, Exchange Rate Effect for EPRX reached as high as $786490.0 in Q4 2023 and fell as low as -$1.3 million in Q4 2024.
• Historically, Exchange Rate Effect has averaged -$225822.2 across 4 years, with a median of -$207141.0 in 2025.
• Across the five-year window, Exchange Rate Effect slumped 262.18% in 2024 and soared 102.66% in 2025, its largest moves.
• Year by year, Exchange Rate Effect stood at $786490.0 in 2023, then slumped by 262.18% to -$1.3 million in 2024, then surged by 102.66% to $33894.0 in 2025, then slumped by 1422.29% to -$448176.0 in 2026.
• Per Business Quant data, the three most recent Exchange Rate Effect figures were -$448176.0 in Q1 2026, $33894.0 in Q4 2025, and -$1.3 million in Q4 2024.